Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.13.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.13.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.10.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.10.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.10.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.10.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GS.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GS.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HG.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HG.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HG.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HG.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.323ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.323ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.323ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.323NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FU.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FU.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.74ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.74NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.53ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.53NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JB.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used